How is Ipamorelin administered?
This describes how Ipamorelin is typically administered in clinical and research references, not a self-administration guide. The usual route is Subcutaneous, on a 1-3x daily schedule, generally over 8-12 weeks on, 4 weeks off. Specific dosing is individual and beyond general information, and human evidence for Ipamorelin is limited.
Administration at a glance (reference data)
- Route: Subcutaneous
- Schedule: 1-3x daily
- Cycle length: 8-12 weeks on, 4 weeks off
- Half-life: ~2 hours
References
- Ipamorelin, the first selective GH secretagogue — Raun K et al., Eur J Endocrinol, 1998
- Prospective, randomized, controlled, proof-of-concept study of the ghrelin mimetic ipamorelin for the management of postoperative ileus in bowel resection patients — Beck DE et al., International Journal of Colorectal Disease, 2014
- Injectable Peptides in Sports Medicine: A Structured Narrative Review of Evidence, Safety, and Antidoping Implications — Villegas Meza AD et al., JBJS Reviews, 2026
Pepdex is an editorial reference, not medical advice. Peptides vary in legal and approval status by country, many are research compounds without full human safety data. Talk to a qualified clinician before starting anything.
More on Ipamorelin
Full Ipamorelin breakdownIpamorelin what it's used forIpamorelin side effectsIpamorelin mistakes to avoidIpamorelin who should avoid itIpamorelin half-lifeIpamorelin how long to workIpamorelin legal statusIpamorelin how it worksipamorelin vs cjc 1295mk 677 vs ipamorelinipamorelin vs tesamorelinhexarelin vs ipamorelinAsk the AI Coach
Last updated 2026-06-15.